https://clinicaltrials.gov/ct2/show/NCT03777436?type=Intr&cond=Psoriasis&lupd_s=04%2F17%2F2019&lupd_d=14
Condition : Psoriasis
Interventions : Drug: Apremilast; Other: Placebo
Sponsor : Celgene
Recruiting
An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis
NCT03777436
Mon, 17 Dec 2018 12:00:00 EST
Last Update Posted: 05/01/19 08:00AM
